Plans for an IPO seem to be maturing at Ripple, according to US media reports. CEO Brad Garlinghouse has been thinking out loud about it since as early as 2020. But what happens to XRP when Ripple is traded on the stock exchange?
At the end of September, the company celebrated its historic victory in the lawsuit with the U.S. Securities and Exchange Commission (SEC) with a big party in New York. In the run-up, information is circulating in US media that CEO Brad Garlinghouse would also like to use the occasion to announce an IPO of Ripple Labs. He had already talked about wanting to take Ripple public in early 2020. However, investors are wondering what impact the plan could have on the cryptocurrency XRP.
Ripple Labs is the crypto company that sees its core business as establishing XRP as a bridge currency for international money transfers. In mid-July, a court in New York cleared XRP of SEC charges of representing securities (“securities”). This should clear the way for a stock market debut of Ripple Labs. Major investor SBI Group had called for an IPO of Ripple in April 2021 for the period after the proceedings with the SEC.
Read more about Ripple and find the latest financial news of the day with our companion app Born2Invest.
From the perspective of analysts, this could trigger positive effects for the price curve of XRP in the medium and long term
That is because the company would predictably attract a lot of attention during its IPO, which would automatically rub off on XRP. Because the SEC would also have to approve Ripple’s IPO plans, XRP should finally be considered a legitimate cryptocurrency after that. New XRP investors could line up with Ripple investors, creating momentum. Ripple, in turn, would get fresh capital through an IPO to fund international expansion.
In its most recent funding round to date, in December 2019, Ripple was valued at around $10 billion. In January 2022, Ripple bought back the shares it sold in 2019 at a 50 percent premium and subsequently valued itself at $15 billion.
Bottom line: Ripple going public could boost XRP price curve
The last IPO of a major crypto company was more than two years ago with Coinbase in April 2021. So Ripple would be hitting a market where publicly traded crypto companies are scarce, while demonstrating innovation.
XRP, the flagship of Ripple, is currently trading at around $0.50, with an all-time high of $3.84 dating back to the beginning of 2018. Optimists hope that XRP could even trend towards new all-time highs with an IPO of Ripple.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
AbolerIS Pharma Closes a Round of €27 Million Led by Caixa Capital
AbolerIS Pharma is a biopharmaceutical company focused on revolutionizing immunotherapy for autoimmune and inflammatory diseases. Through an innovative antibody therapy...
The European Car Market Could Become Completely Sustainable by 2025, with the Adoption of Smaller EVs
According to an estimate by Transport & Environment, the six big European car manufacturers have abandoned the production of cheaper...
Mamacrowd Launches Five Campaigns with November 10th Deadline
To date, no Italian platform has obtained European authorization, so platforms cannot operate after November 10th. In the uncertainty, Mamacrowd...
Why Are Mexican Fintech Companies Increasingly Investing in Small Banks
Banks are not the only regulated institutions that fintech companies are investing in. Others are doing so with popular financial...
Vertex Obtains EMA Validation to Expand Indications for Kaftrio
Vertex is a global biotech company that invests in scientific innovation to create medicines for people with serious diseases. The...
Business7 days ago
Five Travel Stocks Investors Can’t Seem To Get Enough Of This Year
Fintech2 weeks ago
Banca Progetto Funding in Q1 Reaches €5 Billion and Disbursement to SMEs €1.5 Billion
Markets3 days ago
An Interesting Volatile Week for the Stock Markets
Fintech1 week ago
DeluPay Payment Method Comes with Fewer Commissions Paid by (e)-merchants